1 / 44

Vasopressors

Vasopressors. Jennifer & Joshua Chalk Talk 1/17/2014 Go Hawks!. Vasopressors. What? When? Why? Wprecautions?. Vasopressors. Definitions. Pressor: Increases blood pressure by stimulating constriction of blood vessels Increases vascular tone. Definitions.

terena
Download Presentation

Vasopressors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vasopressors Jennifer & Joshua Chalk Talk 1/17/2014 Go Hawks!

  2. Vasopressors What? When? Why? Wprecautions?

  3. Vasopressors

  4. Definitions • Pressor: Increases blood pressure by stimulating constriction of blood vessels • Increases vascular tone

  5. Definitions • Inotrope: Alters force or energy of muscular contractions • Positive: Increases myocardial contractility

  6. Definitions • Shock: Inability of oxygen delivery to meet tissue oxygen requirements • Hypovolemia (decreased circulating volume) • Cardiac function impairment (decreased myocardial contractility) • Inappropriate distribution of cardiac output secondary to abnormal vasodilatation

  7. Pathophysiology • Cardiac output • Heart Rate • Sympathetic and Parasympathetic tone • Circulating chatecolamines • Preload • Changes in venous return • Changes in plasma volume • Contractility • Sympathetic tone • Circulating catecholamines

  8. Progression to Late Shock

  9. Septic Shock • Hypotension despite adequate fluid resuscitation • Presence of hypoperfusion or organ dysfunction • Acidosis / alteration in mental status • Sepsis: temp >38°C or <36°C; HR> 90 bpm* respiratory rate>20 breaths/min, need for mechanical ventilation; WBC 12,000*

  10. Hemorrhagic Shock Rapid reduction in blood volume Heart rate and blood pressure responses can be variable Vasopressors may be harmful if pt is hypovolemic; Despite improvement in blood pressure, renal blood flow decreases and renal vascular resistance rises

  11. Cardiogenic Shock Pump failure Results when more than 40% of myocardium damaged Similar circulatory and metabolic changes to hemorrhagic shock

  12. Treatment • Fluids / Procedures • DRUGS! • Vasopressors • Inotropes

  13. Fluid Requirements • “There is no evidence-based support for one fluid-type over another”(surviving sepsis) • Early fluid administration more important than fluid type • HES/Albumin/Gelatin/LR; Rivers et al

  14. Pharmacology

  15. Pharmacology • Adrenergic System • Alpha adrenergic • Increases vascular tone • May decrease cardiac output • May decrease regional blood flow (renal, spleen, cutaneous) • Beta adrenergic • Maintains blood flow • May increase cellular metabolism • May decrease immune system

  16. Pharmacology • Dopaminergic • Increases splanchnic and renal perfusion • Facilitates resolution of lung edema • Associated with harmful immunological effects • May decrease prolactin, human growth hormone

  17. Vasopressors Norepinephrine Dopamine Epinephrine Vasopressin Phenylephrine

  18. Vasopressors Phenylephrine

  19. Vasopressors

  20. Vasopressors Vasopressin

  21. Receptors

  22. Receptors

  23. Norepinephrine Historically considered a poor choice in shock due to excessive vasoconstriction and end-organ hypoperfusion This opinion began to change recently Benefits: raise arterial pressure and systemic vascular resistance Maintain cardiac function / improve renal function

  24. Dopamine More potential for arrhythmias/increased heart rate May increase both blood pressures and flow; may be best used in patient with low heart rate and inadequate fluid resuscitation

  25. Epinephrine Epi often used as 3rd line after NE and DA failed Epi always first line in Anaphylactic Shock

  26. Vasopressin Vasopressin works on V1,V2,V3 receptors Increases bp / may improve mortality May decrease NE requirements May improve renal function Avoid in MI; in cardiac ischemia may decrease contractility/lower CO/increase mortality At doses > 0.04 units/hr may decrease GI blood flow

  27. Studies • VASST • Vasopressin (0.03 un/hr) v. NE in septic shock • No significant difference in mortality at 28 days • Decreased mortality in patients with less severe septic shock (lowest quartile of arterial lactate) • Vaso + corticosteroids decreased mortality v. NE + corticosteroids • Conclusion: May be effective in patients with less severe septic shock already receiving NE

  28. Studies • Martin: Norepi in Septic Shock • 97 patients in septic shock • Dopamine started at 5mcg/kg/min, titrated to 15mcg/kg/min • If hypotension persisted: • DA increased to 25mcg/kg/min OR • NE added at 0.5mcg/kg/min

  29. Martin et al Patients receiving NE had best survival rate on all days of hospital stay (p<0.001) Mortality strongly associated with high lactate and low urine output “NE was associated with a highly significant decrease in hospital mortality. The data contradict the notion that norepinephrine potentiates end organ hypoperfusion through excessive vasoconstriction

  30. Studies • De Backer: Norepi v Dopamine in Shock. • Multicenter study, 1679 patients • DA with 52.5% mortality • NE with 48.5% mortality (p=0.10) • More arrhythmic events with DA (207v102)

  31. DeBacker et al Included Septic (62.2%), Cardiogenic (16.7%), and Hypovolemic (15.7%) shock. More patients in DA group required 2nd pressor Subgroup: DA in cardiogenic shock increased mortality significantly (p=0.03) Conclusion: “This study raised serious concern about the safety of Dopamine”

  32. Practical Considerations • Vascular Access • Access to drug • Compatibilities • Titration • Adverse effects

  33. Central vs. Peripheral line Central always preferred Peripheral Line Must flush well As big as possible Preferred infusion site = forearm (basilic, cephalic, and median antebrachial) Caution with dorsum of hand, wrist, feet Decision: life vs. limb MD must be aware Guardrails alert: pressor must go through central line Override with MD approval documented Slower titration with obese patients

  34. Central vs. Peripheral line Jean-Damien, R et al. Central or peripheral catheters for initial venous access of ICU patients Patients randomized: peripheral (N=128) or central access (N=135) Included epinephrine/norepinephrine doses up ~0.4 mcg/kg/min (for 75 kg patient); Dopamine/dobutamine doses up to 10 mcg/kg/min Less major complications with central rather than peripheral access (0.64 vs. 1.04, p<0.02) Majority of complications in PIV group were inability to insert PIV Subcutaneous diffusion (aka extravasation) More with peripheral rather than central access 19/128 (~15%) vs. 2/135 (~1.5%) Average length of stay ~12 days All patients managed with “observation and conservative management” http://emcrit.org/podcasts/peripheral-vasopressors-extravasation/ Ricard JD, et al. Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med. 2013 Sep;41(9):2108-15

  35. Extravasation

  36. Extravasation Phentolamine Short-term alpha-adrenergic blocking activity Administration →vasodilatation of vascular smooth muscle Administer ASAP Infiltrate area of extravasation with phentolamine: 5 mg diluted in 9 mL NS Should see near immediate effects; otherwise consider additional dose (Max = 10 mg)

  37. Getting a Drip Up and On Sequence of events Hypotensive patient Recognize pressor needed Physician orders Order recognized in ORCA Pharmacy technician makes drip Pharmacist checks drip Pharmacy technician tubes drip Nurse collects from tube station Nurse starts drip

  38. Getting a Drip Up and On Dopamine, Dobutamine Premixed and in PYXIS! Epinephrine, Phenylephrine, Norepinephrine, Vasopressin Mixed by technician after order received in inpatient pharmacy

  39. Getting a Drip Up and On Persistent hypotension → Ask MD if drip should be sent to bedside Cost to hospital per bag: $1.56 – 7.23 Call pharmacy Ask for pharmacist STAT (state you are calling from ED) State patient scenario briefly Request pharmacy to start making drip ONLY Physician may give verbal order with U#, drug and dose Otherwise MD must place order in ORCA before drip is sent Request pharmacy to notify PSS when drip sent

  40. Compatibilities Variable – Call pharmacy Most likely to be compatible: Epinephrine, dobutamine, dopamine, vasopressin Maybe: Phenylephrine Generally not tested: Norepinephrine

  41. Titration Starting a drip MD must order Generally best to start low and increase Adverse effects frequently dose related Switching a patient from OSH Check patient weight and dosing UNITS If the same, transition to UW pump and drug If different: Call pharmacy to convert Start in the low to mid range of dosing and titrate

  42. Adverse Reactions

  43. References De Backer D et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89. Martin C et al. Effect of norepinephrine on the outcome of shock. Crit Care Med 2000; 28:2758 –2765 Perel A. The initial hemodynamic resuscitation of the septic patient according to Surviving Sepsis Campaign guidelines – does one size fit all? Critical Care 2008, 12:223 Russel J. Vasopressin in the management of septic shock. Critical Care 2011, 15:226 Russell JA, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887. Ricard JD, et al. Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med. 2013 Sep;41(9):2108-15

More Related